Seth Martin
Cardiovascular Disease · Baltimore, MDNPI 1861668154
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $122,684 of the $165,928 with a category attached, or 73.9%. 22 manufacturers reported payments, led by Heartflow, Inc. at 25.0% of the total. Among cardiovascular disease clinicians in MD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 139 payments — averaging $1193.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Heartflow, Inc.$41K
- Amgen$32K
- Novartis$23K
- Sanofi-aventis U.S. LLC$22K
- Merck$13K
- AstraZeneca$13K
- plus $22K from 16 others
Across 5 payments — averaging $33,979 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Amgen$170K
What the payments were for
- Consulting fees$122,68474%
- Speaking & faculty fees$31,38619%
- Travel & lodging$3,8772%
- Food & beverage$7,9815%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Heartflow, Inc. | 18 | $41,410 |
| Amgen | 42 | $31,583 |
| Novartis | 13 | $22,510 |
| Sanofi-aventis U.S. LLC | 10 | $21,598 |
| Merck | 17 | $13,401 |
| AstraZeneca | 5 | $13,200 |
| Pfizer | 1 | $4,750 |
| Kaneka Medical America LLC | 6 | $4,422 |
| Premier Healthcare Solutions, Inc. | 2 | $4,000 |
| E.r. Squibb & Sons, L.L.C. | 1 | $3,732 |
| Novo Nordisk | 4 | $2,768 |
| Chiesi USA, Inc. | 2 | $775 |
| Medicure Pharma Inc. | 2 | $577 |
| Regeneron Healthcare Solutions, Inc. | 4 | $306 |
| Regeneron | 3 | $223 |
| Lilly USA, LLC | 2 | $150 |
| Astrazeneca UK Limited | 1 | $135 |
| Corcept Therapeutics | 2 | $133 |
| Esperion Therapeutics, Inc. | 1 | $125 |
| Eko Health, Inc. | 1 | $60 |
| Boehringer Ingelheim | 1 | $48 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FFRct$41,334
- Repatha$25,494
- CRESTOR$5,550
- ELIQUIS$4,750
- LEQVIO$4,089
- DISEASE STATE$3,792
- Ozempic$2,625
- PRALUENT$2,449
- LIPOSORBER$2,432
- Apheresis Machine$1,500
- JUXTAPID$775
- ZYPITAMAG (pitavastatin)$500
- ENTRESTO$220
- EVKEEZA$144
- NEXLETOL$125
- EVENITY$121
- Prolia$121
How this compares
$165,928 in reported general payments places this provider in the 95th percentile of 507 cardiovascular disease providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Repatha SureclickEvolocumab | 68 | $98,022 |
| Praluent PenAlirocumab | 42 | $55,851 |
| Ezetimibe | 51 | $1,413 |
| Rosuvastatin Calcium | 43 | $790 |
| Metoprolol Succinate | 16 | $315 |
| Atorvastatin Calcium | 13 | $168 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Baltimore
- Navin KapurBaltimore$1.5M
- Michael BlahaBaltimore$609K
- Sanjay RajagopalanBaltimore$521K
- Erin MichosBaltimore$257K
- Erika FellerBaltimore$121K
- Charles CummingsBaltimore$114K
- John RickardBaltimore$109K
- Christopher DefilippiBaltimore$101K
- David KassBaltimore$90K
- Hiroshi AshikagaBaltimore$90K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.